BZYR (Burzynski Research Institute) Moat Score: 1/10 (As of Jul. 02, 2026)


What is Burzynski Research Institute Moat Score?

Burzynski Research Institute BZYR +22.13% Moat Score is 1 as of Jul. 02, 2026. Among 1,400 Biotechnology companies, Burzynski Research Institute ranks worse than 52.64% on this metric.

Burzynski Research Institute has the Moat Score of 1, which implies that the company might have No Moat - Very weak/transient advantages.

Burzynski Research Institute has No Moat: Burzynski Research Institute Inc lacks significant market presence, intellectual property, or regulatory advantages. The company does not exhibit strong brand strength, customer loyalty, or cost advantages, resulting in a very weak competitive position.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Burzynski Research Institute might have No Moat - Very weak/transient advantages.

Burzynski Research Institute  (OTCPK:BZYR) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Burzynski Research Institute Moat Score Related Terms

BZYR vs AGTX, EMMA, ATXI: Moat Score Comparison

For the Biotechnology subindustry, Burzynski Research Institute's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burzynski Research Institute Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Moat Score distribution charts can be found below:

* The bar in red indicates where Burzynski Research Institute's Moat Score falls into.


Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 1 mean?
Burzynski Research Institute (BZYR) has a Moat Score of 1 as of Jul. 02, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Burzynski Research Institute ranks #737 out of 1400 companies in the Biotechnology industry, placing it in the top 52.6%.
Is Burzynski Research Institute's Moat Score too high?
Burzynski Research Institute's current Moat Score is 1. The Biotechnology industry median Moat Score is 2.00. Burzynski Research Institute's value of 1 is 50% below this industry median. Based on the distribution chart, Burzynski Research Institute ranks #737 out of 1400 companies in the Biotechnology industry, which is below the industry midpoint.
How does Burzynski Research Institute's Moat Score compare to AGTX and EMMA?
According to the Biotechnology industry distribution chart, Burzynski Research Institute ranks #737 out of 1400 companies for Moat Score. This places Burzynski Research Institute in the lower half of its industry. The industry median Moat Score is 2.00. Burzynski Research Institute's value of 1 is 50% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,400 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Burzynski Research Institute's current Moat Score of 1 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Burzynski Research Institute's current Moat Score is 1. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burzynski Research Institute stock overvalued right now?
Burzynski Research Institute (BZYR) has a current Moat Score of 1. The current Moat Score is 1 and 50% below the Biotechnology industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Burzynski Research Institute (BZYR), the current Moat Score is 1 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Burzynski Research Institute Business Description

Address 9432 Katy Freeway, Houston, TX, USA, 77055
Burzynski Research Institute Inc operates as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.